Smith Group Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $50K | Hold |
|
|||||
|
2019
Q1 | $59K | Sell |
|
|||||
|
2018
Q4 | $212K | Sell |
|
|||||
|
2018
Q3 | $345K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $369K | Sell |
|
|||||
|
2017
Q1 | $276K | Sell |
|
|||||
|
2016
Q4 | $240K | Sell |
|
|||||
|
2016
Q3 | $298K | Hold |
|
|||||
|
2016
Q2 | $444K | Sell |
|
|||||
|
2016
Q1 | $558K | Sell |
|
|||||
|
2015
Q4 | $650K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $12K | Buy |
|
|||||
|
2014
Q4 | $6K | Hold |
|
|||||
|
2014
Q3 | $7K | Sell |
|
|||||
|
2014
Q2 | $19.2M | Buy |
|
|||||
|
2014
Q1 | $6K | Sell |
|
|||||
|
2013
Q4 | $15.9M | Hold |
|
|||||
|
2013
Q3 | $17.8M | Hold |
|
|||||
|
2013
Q2 | $20.4M | Buy |
|